Changes in cell and tissue organization in cancer of the breast and colon

Current Opinion in Cell Biology

Volumn 26, Issue 1, 2014, Pages 87-95

  Hinck, Lindsay ^a   Näthke, Inke ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 29B; TRANSCRIPTION FACTOR GATA 3; VASCULOTROPIN A;

BASOLATERAL MEMBRANE; BREAST; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER LOCALIZATION; CANCER STAGING; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; COLON POLYPOSIS; EPITHELIUM CELL; FIBROBLAST; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CELL POLARITY; COLONIC NEOPLASMS; DISEASE PROGRESSION; EPITHELIAL CELLS; HUMANS; TUMOR MICROENVIRONMENT;

EID: 84889642798     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2013.11.003     Document Type: Review

References (44)

1. Nelson W.J., Dickinson D.J., Weis W.I. Roles of cadherins and catenins in cell-cell adhesion and epithelial cell polarity. Prog Mol Biol Transl Sci 2013, 116:3-23.
2. Preston S.L., Wong W.M., Chan A.O., Poulsom R., Jeffery R., Goodlad R.A., Mandir N., Elia G., Novelli M., Bodmer W.F., et al. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 2003, 63:3819-3825.
3. Barker N., Ridgway R.A., Van Es J.H., Van De Wetering M., Begthel H., Van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
4. Potten C.S., Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990, 110:1001-1020.
5. Coussens L.M., Zitvogel L., Palucka A.K. Neutralizing tumor-promoting chronic inflammation: a magic bullet?. Science 2013, 339:286-291.
6. Jochems C., Schlom J. Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp Biol Med (Maywood) 2011, 236:567-579.
7. Fleming M., Ravula S., Tatishchev S.F., Wang H.L. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol 2012, 3:153-173.
8. Ellenbroek S.I., Iden S., Collard J.G. Cell polarity proteins and cancer. Semin Cancer Biol 2012, 22:208-215.
9. McCaffrey L.M., Montalbano J., Mihai C., Macara I.G. Loss of the par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell 2012, 22:601-614.
10. Xue B., Krishnamurthy K., Allred D.C., Muthuswamy S.K. Loss of par3 promotes breast cancer metastasis by compromising cell-cell cohesion. Nat Cell Biol 2013, 15:189-200.
11. Sansom O.J., Reed K.R., Hayes A.J., Ireland H., Brinkmann H., Newton I.P., Batlle E., Simon-Assmann P., Clevers H., Näthke I.S., et al. Loss of apc in vivo immediately perturbs wnt signaling, differentiation, and migration. Genes Dev 2004, 18:1385-1390.
12. Nelson S., Nathke I.S. Interactions and functions of the adenomatous polyposis coli (apc) protein at a glance. J Cell Sci 2013, 126:873-877.
13. Fatehullah A., Appleton P.L., Näthke I. Cell and tissue polarity in the intestinal tract during tumourigenesis: cells still know the right way up, but tissue organization is lost. Philos Trans Roy Soc 2013.
14. Etienne-Manneville S., Hall A. Cdc42 regulates gsk-3beta and adenomatous polyposis coli to control cell polarity. Nature 2003, 421:753-756.
15. Etienne-Manneville S., Manneville J.B., Nicholls S., Ferenczi M.A., Hall A. Cdc42 and par6-pkczeta regulate the spatially localized association of dlg1 and apc to control cell polarization. J Cell Biol 2005, 170:895-901.
16. Kim N.H., Kim H.S., Kim N.G., Lee I., Choi H.S., Li X.Y., Kang S.E., Cha S.Y., Ryu J.K., Na J.M., et al. P53 and microrna-34 are suppressors of canonical wnt signalling. Sci Signal 2011, 4:ra71.
17. Meng F., Wu G. The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis. Cancer Metastasis Rev 2012, 31:455-467.
18. Scheel C., Weinberg R.A. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 2012, 22:396-403.
19. Chui M.H. Insights into cancer metastasis from a clinicopathologic perspective: epithelial-mesenchymal transition is not a necessary step. Int J Cancer 2013, 132:1487-1495.
20. Thompson S.C. The colony forming efficiency of single cells and cell aggregates from a spontaneous mouse mammary tumour using the lung colony assay. Br J Cancer 1974, 30:332-336.
21. Cho E.H., Wendel M., Luttgen M., Yoshioka C., Marrinucci D., Lazar D., Schram E., Nieva J., Bazhenova L., Morgan A., et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol 2012, 9. 010160.
22. Krebs M.G., Hou J.M., Sloane R., Lancashire L., Priest L., Nonaka D., Ward T.H., Backen A., Clack G., Hughes A., et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 2012, 7:306-315.
23. Hou H.W., Warkiani M.E., Khoo B.L., Li Z.R., Soo R.A., Tan D.S., Lim W.T., Han J., Bhagat A.A., Lim C.T. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci Rep 2013, 3:1259.
24. Yu M., Bardia A., Wittner B.S., Stott S.L., Smas M.E., Ting D.T., Isakoff S.J., Ciciliano J.C., Wells M.N., Shah A.M., et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013, 339:580-584.
25. Shapiro I.M., Cheng A.W., Flytzanis N.C., Balsamo M., Condeelis J.S., Oktay M.H., Burge C.B., Gertler F.B. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 2011, 7:e2181002.
26. Tiwari N., Tiwari V.K., Waldmeier L., Balwierz P.J., Arnold P., Pachkov M., Meyer-Schaller N., Schubeler D., van Nimwegen E., Christofori G. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling ezh2 expression and epigenetic reprogramming. Cancer Cell 2013, 23:768-783.
27. Chen X., Halberg R.B., Burch R.P., Dove W.F. Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition. J Mol Histol 2008, 39:283-294.
28. Wright J.A., Richer J.K., Goodall G.J. Micrornas and emt in mammary cells and breast cancer. J Mammary Gland Biol Neoplasia 2010, 15:213-223.
29. Yoon N.K., Maresh E.L., Shen D., Elshimali Y., Apple S., Horvath S., Mah V., Bose S., Chia D., Chang H.R., et al. Higher levels of gata3 predict better survival in women with breast cancer. Hum Pathol 2010, 41:1794-1801.
30. Chou J., Lin J.H., Brenot A., Kim J.W., Provot S., Werb Z. Gata3 suppresses metastasis and modulates the tumour microenvironment by regulating microrna-29b expression. Nat Cell Biol 2013, 15:201-213.
31. Cimino D., De Pitta C., Orso F., Zampini M., Casara S., Penna E., Quaglino E., Forni M., Damasco C., Pinatel E., et al. Mir148b is a major coordinator of breast cancer progression in a relapse-associated microrna signature by targeting itga5, rock1, pik3ca, nras, and csf1. Faseb J 2013, 27:1223-1235.
32. Sanchez-Tillo E., de Barrios O., Siles L., Cuatrecasas M., Castells A., Postigo A. Beta-catenin/tcf4 complex induces the epithelial-to-mesenchymal transition (emt)-activator zeb1 to regulate tumor invasiveness. Proc Natl Acad Sci U S A 2011, 108:19204-192099.
33. Hlubek F., Spaderna S., Jung A., Kirchner T., Brabletz T. Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and mt1-mmp in colorectal carcinomas. Int J Cancer 2004, 108:321-326.
34. Rossi S., Di Narzo A.F., Mestdagh P., Jacobs B., Bosman F.T., Gustavsson B., Majoie B., Roth A., Vandesompele J., Rigoutsos I., et al. Micrornas in colon cancer: a roadmap for discovery. FEBS Lett 2012, 586:3000-3007.
35. Paterson E.L., Kazenwadel J., Bert A.G., Khew-Goodall Y., Ruszkiewicz A., Goodall G.J. Down-regulation of the mirna-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates emt is involved in cancer progression. Neoplasia 2013, 15:180-191.
36. Davalos V., Moutinho C., Villanueva A., Boque R., Silva P., Carneiro F., Esteller M. Dynamic epigenetic regulation of the microrna-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 2012, 31:2062-2074.
37. Meng X., Wu J., Pan C., Wang H., Ying X., Zhou Y., Yu H., Zuo Y., Pan Z., Liu R.Y., et al. Genetic and epigenetic down-regulation of microrna-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Gastroenterology 2013, 145:426-436. e426.
38. Newton I.P., Kenneth N.S., Appleton P.L., Nathke I., Rocha S. Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection. Mol Biol Cell 2011, 21:3628-3630.
39. Wolf K., Te Lindert M., Krause M., Alexander S., Te Riet J., Willis A.L., Hoffman R.M., Figdor C.G., Weiss S.J., Friedl P. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J Cell Biol 2013, 201:1069-1084.
40. Tang X., Wen Q., Kuhlenschmidt T.B., Kuhlenschmidt M.S., Janmey P.A., Saif T.A. Attenuation of cell mechanosensitivity in colon cancer cells during in vitro metastasis. PLoS ONE 2012, 7:e35044.
41. Soman P., Kelber J.A., Lee J.W., Wright T.N., Vecchio K.S., Klemke R.L., Chen S. Cancer cell migration within 3D layer-by-layer microfabricated photocrosslinked peg scaffolds with tunable stiffness. Biomaterials 2012, 33:7064-7070.
42. Zhang K., Corsa C.A., Ponik S.M., Prior J.L., Piwnica-Worms D., Eliceiri K.W., Keely P.J., Longmore G.D. The collagen receptor discoidin domain receptor 2 stabilizes snail1 to facilitate breast cancer metastasis. Nat Cell Biol 2013, 15:677-687.
43. Chang J.M., Park I.A., Lee S.H., Kim W.H., Bae M.S., Koo H.R., Yi A., Kim S.J., Cho N., Moon W.K. Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer. Eur Radiol 2013, 23:2450-2458.
44. Zlobec I., Minoo P., Terracciano L., Baker K., Lugli A. Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers. Histopathology 2011, 59:482-495.